Literature DB >> 15136112

Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles.

Peter Platteau, Johan Smitz, Carola Albano, Per Sørensen, Joan-Carles Arce, Paul Devroey.   

Abstract

Additional analysis of a multinational, open-label, randomized study comparing highly purified hMG and recombinant FSH in a long protocol revealed that LH activity might favorably influence pregnancy outcome in IVF cycles.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15136112     DOI： 10.1016/j.fertnstert.2003.09.077

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  10 in total

1.  The human cumulus--oocyte complex gene-expression profile.

Authors:  Said Assou; Tal Anahory; Véronique Pantesco; Tanguy Le Carrour; Franck Pellestor; Bernard Klein; Lionel Reyftmann; Hervé Dechaud; John De Vos; Samir Hamamah
Journal:  Hum Reprod       Date:  2006-03-29       Impact factor: 6.918

Review 2.  Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis.

Authors:  Philippe Lehert; Joan C Schertz; Diego Ezcurra
Journal:  Reprod Biol Endocrinol       Date:  2010-09-16       Impact factor: 5.211

3.  Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial.

Authors:  Li Shu; Qianhua Xu; Qingxia Meng; Xue Dai; Yun Zhang; Wei Zhou; Honggang Yi; Jinyong Liu; Chunxiang Wu; Zhen Hou; Yugui Cui; Tin Chiu Li; Jiayin Liu
Journal:  Ann Transl Med       Date:  2019-04

4.  Live-birth rates after HP-hMG stimulation in the long GnRH agonist protocol: association with mid-follicular hCG and progesterone concentrations, but not with LH concentrations.

Authors:  Joan-Carles Arce; Johan Smitz
Journal:  Gynecol Endocrinol       Date:  2012-07-19       Impact factor: 2.260

5.  Exogenous hCG activity, but not endogenous LH activity, is positively associated with live birth rates in anovulatory infertility.

Authors:  Joan-Carles Arce; Johan Smitz
Journal:  Hum Fertil (Camb)       Date:  2011-07-07       Impact factor: 2.767

6.  The ratio of exogenous Luteinizing hormone to Follicle stimulating hormone administered for controlled ovarian stimulation is associated with oocytes' number and competence.

Authors:  Dragos Albu; Alice Albu
Journal:  Biosci Rep       Date:  2020-01-31       Impact factor: 3.840

7.  A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection.

Authors:  Sandro C Esteves; Joan C Schertz; Sidney Verza; Danielle T Schneider; Silval F C Zabaglia
Journal:  Reprod Biol Endocrinol       Date:  2009-10-14       Impact factor: 5.211

8.  Regional clinical practice patterns in reproductive endocrinology: a collaborative transnational pilot survey of in vitro fertilization programs in the Middle East.

Authors:  Eric Scott Sills; Hussein S Qublan; Zeev Blumenfeld; Ahmad Vt Dizaj; Ariel Revel; Serdar Coskun; Imad Abou Jaoude; Gamal Serour; Mamdoh Eskandar; Mohammad Ali Khalili; Aygul Demirol; Krinos Trokoudes; Pelin Ocal; Abdul Munaf Sultan; Benjamin A Lotto; Adele El-Kareh
Journal:  J Exp Clin Assist Reprod       Date:  2007-08-28

9.  Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden.

Authors:  Jaro Wex; Ahmed M Abou-Setta
Journal:  Clinicoecon Outcomes Res       Date:  2013-08-09

10.  Randomized controlled trial comparing embryonic quality in rFSH versus hMG in the IVF protocol with GnRH Antagonist.

Authors:  Rita de Cassia Borges Chapon; Vanessa Krebs Genro; Carlos Augusto Bastos de Souza; João Sabino Cunha-Filho
Journal:  JBRA Assist Reprod       Date:  2021-02-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.